Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
International Journal of Clinical Oncology|November 13, 2021
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world studyRyuji Yasumatsu, Yasushi Shimizu, Nobuhiro Hanai, et al.Head & Neck|August 15, 2020
Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canalCindy H Nabuurs, Wietske Kievit, Nilou Labbé, et al.Head & Neck|November 13, 2023
Extent of thyroidectomy and paratracheal lymph node dissection in total pharyngolaryngectomy for pyriform sinus cancer, and recurrence, survival, and postoperative hypoparathyroidism: A multicenter retrospective studyYosuke Ariizumi, Nobuhiro Hanai, Takahiro Asakage, et al.Frontiers in Immunology|January 27, 2025
Nationwide multi-centric prospective study for the identification of biomarkers to predict the treatment responses of nivolumab through comprehensive analyses of pretreatment plasma exosome mRNAs from head and neck cancer patients (BIONEXT study)Kuniaki Sato, Satoshi Toh, Taku Murakami, et al.Auris, Nasus, Larynx|March 23, 2017
Japanese Clinical Practice Guideline for Head and Neck CancerKen-Ichi Nibu, Ryuichi Hayashi, Takahiro Asakage, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2022
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled TrialNaomi Kiyota, Makoto Tahara, Junki Mizusawa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2026
Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck CancerMakoto Tahara, Naomi Kiyota, Takeshi Kodaira, et al.Oral Oncology|August 7, 2024
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008Hidetoshi Shimizu, Takeshi Kodaira, Naomi Kiyota, et al.Auris, Nasus, Larynx|January 21, 2026
Transoral surgery for hypopharyngeal and laryngeal cancers in Japan: Current status from a nationwide multicenter retrospective studyKoji Araki, Seiichi Yoshimoto, Takashi Fujii, et al.Frontiers in Immunology|August 13, 2024
Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinomaTakahiro Tsujikawa, Kazuchika Ohno, Kei-Ichi Morita, et al.Pageof 17